transcriptional level in vivo. Induction of promyelocytic leukemia protein (PML) mRNA expression in mouse liver is dependent on type I IFN signaling, and association of PML and HDAC with HDAd vector DNA at 24 hr in mouse liver is dependent on type I IFN signaling. WT mice injected with HDAds showed that induction of type I IFN mRNA in the liver is independent of either transgene or promoter sequences of HDAd vector DNA. This type I IFN signaling also induces transgene silencing of HDAd vectors encoding mammalian transgenes (eukaryotic sequence) at transcriptional level in livers of mice at 24 hr post-injection. We found that HDAd vector coding only eukaryotic sequences is also associated with HDAC and PML and is epigenetically modifi ed in the liver due to type I IFN signaling, suggesting that both prokaryotic and eukaryotic sequences of HDAd vector DNA are epigenetically modifi ed in vivo as a result of type I IFN signaling. These results also suggest that type I IFN signaling induced by infection of Ad-based vectors infl uences the activation of multiple pathways to suppress the transgene expression of Ad-based vectors following their systemic administration.
transcriptional level in vivo. Induction of promyelocytic leukemia protein (PML) mRNA expression in mouse liver is dependent on type I IFN signaling, and association of PML and HDAC with HDAd vector DNA at 24 hr in mouse liver is dependent on type I IFN signaling. WT mice injected with HDAds showed that induction of type I IFN mRNA in the liver is independent of either transgene or promoter sequences of HDAd vector DNA. This type I IFN signaling also induces transgene silencing of HDAd vectors encoding mammalian transgenes (eukaryotic sequence) at transcriptional level in livers of mice at 24 hr post-injection. We found that HDAd vector coding only eukaryotic sequences is also associated with HDAC and PML and is epigenetically modifi ed in the liver due to type I IFN signaling, suggesting that both prokaryotic and eukaryotic sequences of HDAd vector DNA are epigenetically modifi ed in vivo as a result of type I IFN signaling. These results also suggest that type I IFN signaling induced by infection of Ad-based vectors infl uences the activation of multiple pathways to suppress the transgene expression of Ad-based vectors following their systemic administration. Human species C-based adenovirus vectors (HAdvC) induce potent innate immune and infl ammatory responses after intravascular delivery. The molecular basis for the recognition of HAdvC by the innate immune system remains poorly characterized. Macrophages residing in various tissues effi ciently trap HAdvC from the blood. However, while in the blood, type C HAdv2 and HAdv5 bind 240 copies of coagulation factor X with low-nanomolar to picomolar affi nity. Because coagulation factor activation may trigger systemic inflammation, we hypothesized that FX binding to HAdv may contribute to virus recognition by the innate immune system and activation of a systemic infl ammatory response. To test this hypothesis, we analyzed whether protease-activated receptor 2, PAR2, a natural sensor of activated coagulation factors FXa, and FVIIa, on cell surface, is activated by adenovirus-bound FX. Our in vitro analyses revealed that when HEK293-Blue reporter cells that express SEAP gene under the control of NF-κB-dependent promoter were transfected with PAR2-expressing plasmid, HAdv5-FX complex, but not FX or HAdv5 alone, activated NF-κB signaling. Furthermore, the highest levels of NF-κB activation by HAdv5-FX complexes were observed when reporter cells were trasnfected with plasmids, expressing both PAR2 and Toll-like receptor 4 (TLR4). The analyses of NF-κB-dependent gene activation in mice defi cient for key mediators of infl ammation revealed that the expression of infl ammatory cytokines and chemokines was activated through MyD88/TRIF/TRAF6 signaling and required both TLR4 and PAR2 as critical sensors that trigger NF-κB-dependent gene activation. We further analyzed activation of a panel of cytokines and chemokines in response to a number of wild type HAdvs and found that those virus species that bind FX activate a broader spectrum of cytokines and chemokines, compared to wild type HAdvs that do not bind FX. Our study implicates host factor "decoration" of the adenovirus as a mechanism to cooperatively trigger PAR2 and TLR4 innate immune sensors that respond to a misplacement of FX from the blood into intracellular macrophage compartments upon virus entry into the cell. This fi nding may prove useful for defi ning strategies and pharmacological approaches to moderate severe infl ammatory responses to HAdv-based gene therapy vectors and may aid in the design of more effective vaccination strategies. Intravascular delivery of adenovirus 5 (Ad5) is an attractive route for targeting the vasculature at defi ned sites and disseminated cancer. However upon contact with the blood, a high affi nity interaction between the Ad5 hexon protein and coagulation factor X (FX) leads to substantial liver gene transfer, combined with sequestration by Kupffer cells, this limits the availability of the virus for targeting to other sites. The aim of this study was to use a high throughput approach to screen a compound library in search of an inhibitor of Ad5:FX-mediated gene transfer. We developed a fl uorescence based high throughput assay using SKOV3 cells (CARlow) seeded in a 384well microplate format to analyse FX-mediated Ad5GFP infection. This robust assay provided clear positive and negative controls and was used to screen 10,240 low molecular weight compounds from the 'Pharmacological Diversity Drug-Like Set' library, provided by the chemical supply company Enamine (www.enamine.net). Using an integrated liquid handling platform (Beckman Coulter BioMek FXP) cells were infected with Ad5GFP in the presence of physiological concentrations of FX (10 μg/ml) and 10 μM of each compound in triplicate. 48 h post-infection GFP expression was analysed using high-content cellular screening microscopy (GE Healthcare IN Cell Analyzer 2000) . Employing a 75% decrease in FX-mediated Ad5GFP expression as the criterion for further evaluation 288 compounds were identifi ed (∼2.8% hit rate) in the initial screen. All potential hits were rescreened to re-evaluate the compound activity both manually and using screening robotics. Any compounds causing toxicity as assessed by propidium iodide staining and MTS assay were disqualifi ed. Upon completion of these assays, 3 compounds (T5424837, T5550585 and T5660138) inhibited Ad5:FX gene transfer using the above criteria without causing any cytotoxicity. These candidate compounds were further analysed to determine IC50 values, all of which were below 5 μM. The effect of the compounds on cellular binding and cytosolic transport was assessed in vitro. Compound T5424837 caused a signifi cant reduction in FX-mediated Ad5 cellular binding as shown using qPCR and all compounds prevented effi cient Ad5 intracellular traffi cking to the microtubule organising centres in the presence of FX as demonstrated using confocal microscopy. The candidate hits have common structural features and fall into the one pharmacophore model, initially established by Enamine. New smaller focused libraries were generated related to the chemical structures, space occupied by the hits and desirable pharmacokinetic properties. When tested in vitro several of the compound analogues prevented FXmediated Ad5 gene transfer to similar or greater levels than the parent compound. The lead compounds will undergo chemical optimisation steps and will be tested in vivo for effects on the biodistribution of Ad5. Such an inhibitor of Ad5:FX gene transfer would hold promise for improving the therapeutic viability of this vector for targeted gene transfer following intravascular delivery.
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